Related Experiment Video
Updated: Sep 30, 2025
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.1K
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li1, Shoubao Ma2, Youcai Deng3
1Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, P. R. China.
Molecular Cancer
|March 17, 2022
Summary
N6-methyladenosine (m6A) RNA modifications impact cancer immunity by affecting immune cells and the tumor microenvironment. Targeting m6A regulators offers new strategies to enhance cancer immunotherapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- N6-methyladenosine (m6A) is the most prevalent RNA epigenetic modification.
- m6A dysregulation is linked to aberrant gene expression driving cancer.
- m6A influences tumor immunogenicity and anti-tumor immune responses.
Purpose of the Study:
- To provide a comprehensive overview of m6A's role in cancer immunity.
- To explore how m6A modifications affect immune cells intrinsically and extrinsically within the tumor microenvironment (TME).
- To review strategies for modulating m6A to improve cancer immunotherapy.
Main Methods:
- Review of current literature on m6A modifications in cancer and immunity.
- Analysis of m6A's intrinsic effects on immune cells.
- Examination of extrinsic effects of tumor m6A on the TME.
- Discussion of therapeutic strategies targeting m6A regulators.
Main Results:
- m6A modifications intrinsically affect immune cell function.
- Tumor m6A alterations extrinsically modulate immune cell responses in the TME.
- Several strategies are proposed for targeting m6A to enhance anti-tumor immunity.
Conclusions:
- Understanding m6A's dual role in cancer immunity is crucial for therapeutic development.
- Targeting m6A regulators, alone or in combination with other therapies, holds promise for improving cancer immunotherapy outcomes.
- Future research should focus on developing effective m6A-based strategies to reshape the TME and boost anti-tumor immunity.
Related Concept Videos
01:22MicroRNAs
3.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
02:23RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
01:53RNA Stability
34.0K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K